Pancreato-hepatobiliary disease in IgG4-RD

When IgG4-related disease (IgG4-RD) affects organs of the digestive system, it often involves areas like the pancreas, liver, and bile ducts, which carry the digestive fluid bile from the liver into the intestines. This form of the condition is often referred to as pancreato-hepatobiliary disease.

Pancreato-hepatobiliary disease is a complex term that simply refers to diseases of the pancreas (“pancreato”), liver (“hepato”), and bile ducts (“biliary”).

Understanding the IgG4-RD clinical profile, and how it’s diagnosed and treated, can help you prepare for what to expect.

What is pancreato-hepatobiliary disease in IgG4-RD?

In IgG4-RD, immune cells accumulate in organs and tissues, leading to ongoing inflammation. Over time, this may cause swelling and thickening of nearby tissues, resulting in lump-like areas that may look similar to tumors on imaging scans.

In pancreato-hepatobiliary disease, these issues mainly affect the pancreas and bile ducts, although the liver may also be affected in some cases. Common conditions associated with IgG4 pancreatic and bile duct disease include:

• IgG4 autoimmune pancreatitis type 1, the most common manifestation of pancreato-hepatobiliary disease, which refers to inflammation of the pancreas
• IgG4 sclerosing cholangitis, in which inflammation causes the bile ducts to become narrow or blocked

Common symptoms

Symptoms of pancreato-hepatobiliary disease depend on which organs are affected and the extent of damage.

Problems may arise when the normal flow of bile is disrupted or when the disease affects how the pancreas works. Many symptoms are related to digestion issues or bile buildup in the body. They may include:

• jaundice (yellowing of the skin or eyes)
• abdominal pain and bloating
• indigestion
• unintended weight loss
• fever
• pruritus (itching)

How pancreato-hepatobiliary disease is diagnosed

Diagnosing pancreato-hepatobiliary disease requires collecting several types of information. Your doctor will review your symptoms, imaging scans, blood test results, and sometimes biopsies.

Common tests include:

• Imaging scans: CT, MRI, or ultrasound may show an enlarged pancreas, bile duct narrowing, or mass-like areas.
• Blood tests: These may check IgG4 antibody levels and other signs of inflammation. However, blood tests alone can’t confirm or rule out the disease.
• Biopsy: A small tissue sample may be examined under a microscope to look for immune cells and scarring patterns typical of IgG4-RD.

These tests can also help rule out other conditions, such as pancreatic cancer or bile duct disease, which can look similar on scans.

Treatment options

Treatment for pancreato-hepatobiliary disease focuses on reducing inflammation and preventing irreversible organ damage. Many people improve quickly once treatment begins, especially if started early, before tissues become permanently scarred.

Common treatment approaches include:

• Corticosteroids: A first-line treatment that reduces immune-driven inflammation
• Immune-modulating therapies: May be used if symptoms return after discontinuing steroids or if steroids can’t be used
• Procedures for bile duct blockage: Doctors place a stent (small tube) to keep the narrowed bile ducts open and improve the flow of bile

Potential complications

Without prompt treatment, ongoing inflammation can lead to lasting damage in the pancreas or bile ducts. Over time, fibrosis (scar tissue) may form, interfering with normal organ function.

Possible long-term complications of pancreatic involvement in IgG4-RD may include:

• Pancreatic insufficiency: The gland cannot produce enough digestive enzymes and insulin, a hormone that controls blood sugar
• Diabetes: If insulin production is affected, oral medications may be needed

Early treatment is important for preventing the progression of inflammation and fibrosis and for improving long-term outcomes.

Long-term outlook

The long-term outlook is often good when pancreato-hepatobiliary disease is diagnosed and treated early. Many people with IgG4 autoimmune pancreatitis have a normal life expectancy, even if complications occur.

However, the disease can relapse (return), especially when multiple organs are involved. This can lead to increased fibrosis, which can affect pancreatic or bile duct function over time.

Ultimately, while living with a rare disease can be challenging, with regular care and good communication with your healthcare team, you can manage the condition and maintain a good quality of life.